Design and evaluation of Itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy

Pakistan Journal of Pharmaceutical Sciences

Volumn 22, Issue 2, 2009, Pages 131-138

  Mukherjee, Swarupananda ^a   Ray, Subhabrata ^a   Thakur, R S ^a  

^a KRUPANIDHI COLLEGE OF PHARMACY   (India)

Author keywords

DSC; Itraconazole; Micrormulsion; Optimization; Pluronic; SLN; XRD

Indexed keywords

ITRACONAZOLE; PALMITIC ACID; POLOXAMER; POLYSORBATE 40; SOLID LIPID NANOPARTICLE; ANTIFUNGAL AGENT; DRUG CARRIER; NANOPARTICLE; POLYSORBATE; SURFACTANT;

ARTICLE; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; MICROEMULSION; PARTICLE SIZE; ZETA POTENTIAL; ANIMAL; CHEMISTRY; EVALUATION; FEASIBILITY STUDY; ILEUM; IN VITRO STUDY; INTESTINE ABSORPTION; KINETICS; METABOLISM; METHODOLOGY; OSMOLARITY; PERMEABILITY; PH; PHARMACEUTICS; RAT; SOLUBILITY;

ANIMALS; ANTIFUNGAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DESIGN; FEASIBILITY STUDIES; HYDROGEN-ION CONCENTRATION; ILEUM; INTESTINAL ABSORPTION; ITRACONAZOLE; KINETICS; NANOPARTICLES; OSMOLAR CONCENTRATION; PALMITIC ACID; PARTICLE SIZE; PERMEABILITY; POLOXAMER; POLYSORBATES; RATS; SOLUBILITY; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL;

EID: 65449185438     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Alonso MJ and Torres D (2002). Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids and Surface B: Biointerfaces., 27: 159-170.
2. Capek I (2004). Preparation of metal nanoparticles in water-in-oil (w/o) microemulsions. Adv. Colloid. and Inter Sci., 110: 49-74.
3. Chasteigner DS, Fessi H, Devissaguet JP and Puisieux F (1996). Comparative study of the association of itraconazole with colloidal drug carriers. Drug Dev. Res., 38: 125-133. (Pubitemid 26400606)
4. Chi S and Rhee Y (2001). Transdermal delivery of ketoprofen using microemulsion. Int. J. Pharm., 228: 159-168.
5. Drake B, Prater CB, Weisenhorn AL, Gould SAC, Albrecht TR, Quate CF, Cannel DS, Hansma HG and Hansma PK (1989). Imaging crystals polymers and process in water with the AFM. Science, 243: 1586-1589.
6. Ghorab Mamdouh M and Heba M Abdel-Salam (2005). Effects of Glycerides on the intestinal absorbtion of cyclosporine a using the in-situ mesenteric vein cannulated rat model. Current Drug Deliv., 2: 289-294.
7. thed. New York, MC Graw-Hill Publishing House, p.1972.
8. Heykants J, Peer V, Van de Velde V, Roopy PV, Meuldermans W, Lavrjsen K, Woestenborghs R, Van Cutsem J and Cauwenberg G (1989). The clinical pharmacokinetics of itraconazole: an overview. Mycoses., 32: 67-68.
9. Hu L, Tang X and Cui F (2004). Solid lipid Nanoparticles (SLNs) to improve oral bioavaility of poorly soluble drug. J. Pharm. Pharmacol., 56: 1527-1535. (Pubitemid 39601993)
10. Kim B, Na K and Choi H (2005). Preparation and Charecterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan. Eur. J. Pharm. Sci., 24: 199-205. (Pubitemid 40127550)
11. Laggner P (1999). X-ray diffraction of lipids, in: Hamilton RJ, Cast J (Eds.), spectral properties of lipids sheffield Academic Press, Sheield, pp.327-367.
12. Lim S, Lee M and Kim C (2004). Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticles powders. J. Control. Release, 100: 53-61. (Pubitemid 39445985)
13. Mehnert W and Madder K (2001). Solid lipid nanoparticles production, characterization and application. Adv. Drug Deliv. Rev., 47: 165-196.
14. Meyer E and Heinzelmann H (1992). Scanning force microscopy. In: Wiesendanger R and Guntherodt HJ (Eds.), Scanning tunneling microscopy II, Surface science 28, Springer verlag, Berlin, New York, pp.99-149.
15. Muller RH and Keeck CM (2004). Drug delivery to the brain-realization by novel drug carriers. J. Nanosci. Nanotechnol., 4: 471-483.
16. Muller RH, Radtke M and Wissing SA (2002a). Nanostructered lipid matrices for improved microencapsulation of drugs. Int. J. Pharm., 242: 121-128. (Pubitemid 34899443)
17. Muller RH, Radtke M and Wissing SA (2002b). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug. Deliv. Rev., 54: S131-155. (Pubitemid 35379959)
18. 3 fractional design. AAPS Pharma Sci. Tech., 4(4): 1-11.
19. Sarciqux JM, Acar L and Sado PA (1995). Using micro emulsion formulations for oral drug delivery of therapeutic peptides. Int. J. Pharm., 120: 127-136.
20. Souto EB and Muller RH (2006). Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J. Microencapsul., 23: 377-388.
21. Souto EB, Muller RH (2005). SLN and NLC for topical delivery of ketoconazole. J. Microencapsul., 22: 501-510.
22. Souto EB and Muller RH (2006). The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents. Pharmazie., 61: 431-437.
23. Souto EB, Wissing SA, Barbosa CM and Muller RH (2004). Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm., 278: 71-77.
24. Tabatt K, Kneuer C, Sameti M, Olbrich C, Muller RH, Lehr CM and Bakowsky U (2004). Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes. J. Control. Release, 97: 321-332. (Pubitemid 38759489)
25. Uner M (2006). Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Pharmazie., 61: 375-386.
26. Vyas SP and Khar RK (2002). Multiple emulsion, Nanoparticles, In: Targeted and Controlled Drug Delivery.1st ed. New Delhi: CBS Publishers, pp.303-380.
27. Yang X, Mei Z and Chen H (2003). Solid lipid nanoparticles and microemulsion for topical delivery of triptolide. Euro. J. Pharm. Bio. Pharm., 56: 189-196. (Pubitemid 37072102)
28. Venkateswarlu V and Manjunath K (2004). Preparation, Charecterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J. Control Release, 95: 627-638. (Pubitemid 38344153)
29. Wissing SA, Kayser O and Muller RH (2004). Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug. Deliv. Rev., 56: 1257-1272. (Pubitemid 38510473)